Status:
COMPLETED
The Impact of Pharmacists' Interventions on the Quality of Life of HIV-TB Co-infection Outpatients in Indonesia
Lead Sponsor:
Bekasi City Public Hospital
Collaborating Sponsors:
University of Groningen
Conditions:
Pharmaceutical Care
HIV/AIDS
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: The co-infection of human immunodeficiency virus (HIV) and tuberculosis (TB) diseases presents further problems to patient's adherence due to high pill burden and adverse effects in the dr...
Detailed Description
1. STUDY BACKGROUND 1.1 HIV and TB Diseases Human Immunodeficiency Virus (HIV) is a global health concern which the World Health Organization (WHO) estimates that 36.7 million people are living wi...
Eligibility Criteria
Inclusion
- patients aged 18 years or older;
- diagnosed with the HIV disease and co-infected with the definite TB disease (PTB or EPTB) during the study period, proven by geneXpert (if applicable), positive smear sputum, and chest X-ray;
- definite TB patients who are found infected with HIV;
- attending for outpatient care;
- can read and write in Indonesian language;
- not pregnant;
- taking ARV/HAART at the time of research and is just about to start TB treatment and receive first line of TB drugs;
- taking ARV/HAART at the time of research and in TB treatment until maximum 3 months from the first consumption of TB drugs and receive first line of TB drugs;
- HIV patients on TB therapy but have not received ARV/HAART yet;
- and patients who are willing to take part in this study (signing the informed consent).
Exclusion
- Patients who are diagnosed with only the HIV disease or with other non-TB diseases as reported in their medical records, such as hepatitis C;
- patients who have enrolled in another clinical trial that may change the nature of basic treatment;
- patients with limited clinical condition due to their severe condition and therefore are not able to attend outpatient visit, such as stroke.
Key Trial Info
Start Date :
April 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04325438
Start Date
April 1 2017
End Date
March 30 2019
Last Update
March 27 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Persahabatan public hospital
Jakarta, Jakarta Timur, Indonesia
2
Bekasi city hospital
Bekasi, West Java, Indonesia, 17134
3
Ciptomangunkusumo public hospital
Jakarta Pusat, Indonesia